Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
“The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires.”
Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."
According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "…we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."
Avadel Pharmaceuticals announces publication of RESTORE data highlighting challenges with twice-nightly oxybates and strong patient preference for once-nightly LUMRYZ™ dosing (sodium oxybate) extended-release oral suspension (CIII)